Use of Complementary and Alternative Medicine in Gynecologic Cancers

Yıl 2018, Cilt: 1 Sayı: 1, 36 - 47, 13.08.2018

Sibel Peksoy , İlknur Demirhan , Sena Kaplan , Sevil Şahin , Ayten Arıöz Düzgün

Öz

Nowadays, the use of complementary and alternative
medicine (CAM) is becoming widespread gradually in cancer patients. The use of
CAM in gynecological cancers is particularly notable. the use of CAM is
influenced by factors such as age, education, application of chemotherapy and
advanced stage of cancer, in addition to being a female. Gynecologic cancer
patients apply CAM for reducing side effects of medical treatment, supporting
treatment, increasing quality of life, strengthening immune system and
preventing cancer re-occurrence.Although there are many CAM techniques, in the
United States, the National Institutes of Health reduced these to two basic
groups as "natural products" and "body and mind practices".
In patients with gynecologic cancer, the use of CAM, especially of
plant-derived natural products, in combination with medical treatment, may
cause drug interactions and toxicity. At the same time, many women who use CAT
do not report their use of such methods to the health team. For this reason,
health professionals working with cancer patients should interrogate the use of
CAT in detail, and have knowledge to provide guidance on this issue.

Anahtar Kelimeler

Gynecological cancers, complementary and alternative therapies, health professional

Tamamlayıcı ve Alternatif Tedavinin Jinekolojik Kanserlerde Kullanımı

Öz

Günümüzde tamamlayıcı ve
alternatif tedavi (TAT) kullanımı kanser hastalarında giderek
yaygınlaşmaktadır. Özellikle jinekolojik kanserlerde TAT kullanımı dikkat
çekmektedir. Kadın cinsiyetinde olmanın yanında TAT kullanımı yaş, eğitim,
kemoterapi uygulanması ve kanserin ileri evresi gibi faktörlerden
etkilenmektedir. Jinekolojik kanserli hastalar; tıbbi tedavinin yan etkilerini
azaltmak, tedaviye destek olmak, yaşam kalitesini artırmak, bağışıklık
sistemini güçlendirmek ve tekrar kanser oluşumunu önlemek gibi nedenlerle TAT
kullanımına başvurmaktadır. TAT kullanımı çeşitlilik içermekle birlikte,
Amerika Birleşik Devletleri’nde Ulusal Sağlık Enstitüsü bu yöntemleri “doğal
ürünler” ve “beden ve zihin uygulamaları” olarak iki temel gruba indirgemiştir.
Jinekolojik kanserli hastalarda TAT kullanımında özellikle bitkisel kaynaklı
doğal ürünlerin tıbbi tedavi ile birlikte kullanılması ilaç etkileşimlerine ve
toksisiteye neden olabilmektedir. Aynı zamanda TAT kullanan birçok kadın, bu
yöntemleri kullandığını sağlık ekibi ile paylaşmamaktadır. Bu nedenle kanser
hastaları ile çalışan sağlık profesyonelleri TAT kullanımını ayrıntılı
sorgulamalı, bu konuda rehberlik yapabilecek bilgiye sahip olmalıdır.  

Anahtar Kelimeler

Alternatif tedaviler, Jinekoloji, Kanser, Sağlık ekibi, Tamamlayıcı tedaviler

Kaynakça

• 1. National Center for Complementary and Integrative Health [Internet]. Maryland: National Institutes of Health: 2017 [updated 2018 Jun 6]. Available from: https://nccih.nih.gov/health/integrative-health
• 2. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005; 16(4): 655-63.
• 3. World Health Organization. Traditional Medicine. Fact Sheet no. 134. Geneva: World Health Organization; 2008.
• 4. Kav S, Hanoğlu Z, Algıer L. Türkiye'de kanserli hastalarda tamamlayıcı ve alternatif tedavi yöntemlerinin kullanımı: Literatür taraması. UHOD. 2008; 1(18): 32-8.
• 5. Özçelik H, Fadıloğlu C. Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. Türk Onk Derg. 2009; 24(1): 48-52.
• 6. Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD. Use and acceptance of CAM among the general population and medical personel: A systematic review. The Ochsner J. 2012; 12(1): 45-56.
• 7. Türk Tabipler Birliği Halk Sağlığı Kolu. Tıbbın alternatifi olmaz! Geleneksel ve alternatif tamamlayıcı tıp uygulamaları. Ankara: Türk Tabipler Birliği Yayınları; 2017.
• 8. Amanak K, Karaoz B, Sevil U. Alternatif / Tamamlayıcı tıp ve kadın sağlığı. TAF Preventive Medicine Bulletin. 2013; 12(4): 441-8.
• 9. Küçüköner M, Bilge Z, Işıkdoğan A, Kaplan MA, İnal A, Urakçı. Complementary and alternative medicine usage in cancer patients in southeast of Turkey. Afr J Tradit Complement Altern Med. 2013; 10(1): 21-5.
• 10. Özkan İA, Kulakaç Ö. Jinekolojik kanserlerde tamamlayıcı ve alternatif tıp kullanımı: Bir literatür incelemesi. Türkiye Klinikleri, J Med Sci. 2009; 29(6): 1695-704.
• 11. Supoken A, Chaisrisawatsuk T, Chumworathayi B. Proportion of gynecologic cancer patients using complementary and alternative medicine. Asina Pasific J Cancer Prev. 2009; (10):779-82.
• 12. Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, et al. Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol. 2002; 84(3): 363-7.
• 13. Akyüz A, Dede M, Çetintürk A, Yavan T, Yenen MC, Sarıcı SU, et al. Self-application of complementary and alternative medicine by patients with gynecologic cancer. Gynecol Obstet Invest. 2007; 64: 75-81.
• 14. Nazik E, Nazik H, Api M, Kale A, Aksu M. Complementary and alternative medicine use by gynecologic oncology patients in Turkey. Asian Pacific J Cancer Prev. 2012; 13: 21-25.
• 15. Karadağ MG, Türközü D, Kapucu DT. Bitkiler ve ilaç etkileşimleri. Göztepe Tıp Derg. 2013; 28(4): 164-70.
• 16. Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E, et al. Potiential interactions of CAM with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol. 2013; 139: 357-365.
• 17. Smith PJ, Clavarino A, Long J, Steadman KJ. What complementary and alternative medicine (CAM) can I safely use with chemotherapy? Evidence-based information for patients [Internet]. Sunshine Coast Hospital and Health Service. Queensland Government: 2016 [updated 2018 Jun 11]. Available from: https://pdfs.semanticscholar.org/be6c/138382ad276347362e08e1ab097f52b5be8e.pdf
• 18. Aktürk Z, Dağdeviren N, Yıldırım T, Yılmazer AZ, Bulut FG, Subaşı B. What do medical students know about herbs? The recognition of and knowledge on the public use of herbs among phase one and six medical students. Genel Tıp Derg. 2003; 16(3): 101-6.
• 19. Ferlay J, Isabelle S, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality wolrdwide: Sources, methods and major patterns in GLOBACON 2012. Internal Journal of Cancer. 2015; 136: E359-86.
• 20. Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu. Türkiye Kanser İstatistikleri. Ankara: Sağlık Bakanlığı; 2017.
• 21. Ertem G. Jinekolojik kanserlerde evde bakım. Türk Onk Derg. 2010; 25(3): 124-32.
• 22. Molassiotis A, Browall M, Milovics L, Panteli V, Patiraki E, Fernandez-Ortega P. Complementary and alternative medicine use in patients with gynecological cancers in Europe. Int J Gynecol Cancer. 2006; 16 Suppl 1: 219-24.
• 23. Spadacio C, Barros NF. Use of complementary and alternative medicine by cancer patients: systematic review. Rev Saude Publica. 2008; 42(1):1-7.
• 24. Avcı İA, Koç Z, Sağlam Z. Use of complementary and alternative medicine by patients with cancer in northen Turkey: analysis of cost and satisfaction. JCN. 2011; 21: 677-88.
• 25. Taş F, Üstüner Z, Gülbeyaz C, Eralp Y, Çamlıca H, Başaran M, et al. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncol. 2005; 44(2): 161-7.
• 26. Yıldırım Y, Tınar S, Yorgun S, Toz E, Kaya B, Sönmez S, et al. The use of complementary and alternative medicine (CAM) therapies by Turkish women with gynecological cancer. Eur J Gynaecol Oncol. 2006; 27(1): 81-5.
• Referans27. Chase DM, Gibson SJ, Summer DA, Bea JW, Alberts DS. Appropriate use of complementary and alternative medicine approaches in gynecologic cancers. Curr Treat Options Oncol. 2014; 15(1): 14-26.
• 28. Ovayolu Ö, Ovayolu N. Evidence-Based Supplementary Methods For Symptom Management. ERÜ Sağlık Bilimleri Fakültesi Dergisi. 2013; 1(1): 83-98.
• 29. Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, et al. Clinical practice guidelines on the evidenced-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017; 67(3): 195-232.
• 30. Kurt H, Keşkek ŞÖ, Çil T, Canataroğlu A. Meme kanserli hastalarda tamamlayıcı/ alternatif tedavi kullanımı. Türk Onk Derg. 2013; 28(1): 10-15.
• 31. Deng G, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, et al. Evidence-Based Clinical Practice Guidelines for Integrative Oncology: Complementary Therapies and Botanicals. J Soc Integr Oncol. 2009; 7(3): 85–120.
• 32. Zeitlin D, Keller SE, Shiflett SC, Schleifler SJ, Bartlett JA. Immunological effects of massage therapy during academic stress. Psychosom Med. 2000; 62: 83- 84.
• 33. Wilkinson S, Barnes K, Storey L. Massage for symptom relief in patients with cancer: systematic review. JAN. 2008; 63(5): 430-9.
• 34. Falkensteiner M, Mantovan F, Müller I, Christa T. The use of massage therapy for reducing pain, anxiety, and depression in oncological palliative care patients: a narrative review of the literature. ISRN Nurs. 2011; 929868: 1-8.
• 35. Dikmen HA, Terzioğlu F. Effects of reflexology and progressive muscle relaxation on pain, fatigue and quality of life during chemotherapy in gynecologic cancer patients. Pain Manag Nurs. 2018;15: 1-10.
• 36. Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Arvizu R, Mathews HL. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun. 2008; 22(6): 969-81.
• 37. Yeşil H, Kıran B, Alkan H, Ateş B, Kayalı B, Büyükçam S, et al. Afyon Kocatepe Üniversitesi’nde Meme Kanseri Tanısı İle Takip Edilmekte Olan Hastalarda Tamamlayıcı Ve Alternatif Tedavi Kullanımı. Kocatepe Med J. 2018; 19(2): 42-47.
• 38. Olness K. Helping children and adults with hypnosis and biofeedback. Cleve Clin J Med. 2008; 75: 39-43.
• 39. Bradt J, Shim M, Goodill SW. Dance/movement therapy for improving psychological and physical outcomes in cancer patients. Cochrane Database Syst Rev. 2015, Issue 1. Art. No.: CD007103.
• 40. Freitos NMA, Silva TRMA, Freitas-Junior R, Paula Junior W, Silva DJ, Machado GDP, et al. Music therapy reduces radiotherapy-ınduced fatigue in patients with breast or gynecological cancer: randomized trial. Canser Res [Internet]. 2012 [cited 2018 Jun 9]; 72(24): Abstract nr P2-12-04. Available from AACR Publications: http://cancerres.aacrjournals.org/content/72/24_Supplement/P2-12-04
• 41. Teskereci G, Yangın HB. Over kanseri tanısı alan bir kadında aromaterapi ve müzik eşliğinde hayal etme egzersizi uygulaması: olgu raporu. Spatula DD, 2015;5(2):79-8.
• 42. Başgöl Ş, Aslan E. Jinekolojik kanserlerin tedavisinde tamamlayıcı ve alternatif tedavi: Kanıta dayalı yaklaşım. YBÜ Sağlık Bilimleri Fakültesi Hemşirelik E-Dergisi. 2014; 2(3): 51-62.
• 43. Kalkan Ş. Sempozyum, Tıbbın Alternatifi Olmaz. Geleneksel, Alternatif ve Tamamlayıcı Tıp Uygulamalarına Hekim Yaklaşımı [Internet]. İstanbul: Türk Tabipler Birliği; 2016 [updated 2018 Jun 11]. Available from: http://www.toraks.org.tr/userfiles/file/GATT_Metinleri%20V2%20(1)%20(1).pdf
• 44. Alparslan GB, Özkarman A, Eskin N, Yılmaz S, Akay M, Açıkgöz A, et al. Effect of ginger on chemotherapy-ınduced nausea and/or vomiting in cancer patients. J Aust Tradit-Med So. 2012; 18 (1): 15-8.
• 45. Lee J, Oh H. Ginger as an antiemetic modality for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis. Oncol Nurs Forum. 2013; 40(2): 163-70.
• 46. Manusirivithaya S, Sripramote M, Tangjitgamol S, Sheanakul C, Leelahakorn S, Thavaramara T, et al. Antiemetic effect of ginger in gynecologic oncology patients receving cisplatin. Int J Gynecol Cancer. 2004; 14: 1063-9.
• 47. Münsteid K, Maisch M, Tinneberg HR, Hübner J. Complementary and alternative medicine (CAM) in obstetrics and gynaecology: a survey of office-based obstetricians and gynaecologists regarding attitudes towards CAM, its provision and cooperation with other CAM providers in the state of Hesse, Germany. Arch Gynecol Obstet. 2014; 290: 1133-9.
• 48. Dai S, Liu J, Sun X, Wang N. Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43. BMC Complementary & Anternative Medicine. 2014; 14(434): 1-8.
• 49. Jin X, Ruiz Beguerie J, Sze DMY, Chan GCF. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev.2014; Issue 6. Art. No: CD007731.
• 50. Ben-Arye E, Samuels N, Goldstein LH, Mutafoglu K, Omran S, Schiff E, et al. Potential Risks Associated With Traditional Herbal Medicine Use in Cancer Care: A Study of Middle Eastern Oncology Health Care Professionals. Cancer. 2016; 122(4): 598-610.